“…In recent decades, many studies have demonstrated that metabolic disorder of biothiols will lead to extreme damage in human and numerous other animals (Townsend et al, 2003;Reddie and Carroll, 2008;Weerapana et al, 2010). Specifically, a low level of biothiols in vivo may cause slowed growth, liver damage, weight loss, and some other adverse influences (Wang et al, 2005;Duan et al, 2008;Yang et al, 2012), while a high level of biothiols is closely related to Parkinson's, Alzheimer's, and cardiovascular diseases (Heafield et al, 1990;Rusin et al, 2004;Lin et al, 2008;Yang et al, 2011). Thus, a lot of effort has been put into quantifying the lowmolecule-weight biothiols in serum (Ni et al, 2015;Ghasemi et al, 2015).…”